777 abstracts found.



Results filter

CCP Score: A novel genetic test for prostate cancer

Year:

Session type:

Dan Berney1, Michael Brawer2, Matthew Cooperberg3, Gregory Swanson4, Stephen Freedland5, Julia Reid2, Gabrielle Fisher1, Gerry Lanchbury2, Alexander Gutin2, Steven Stone2, Peter Carroll3, Jack Cuzick1
1Queen Mary University of London, London, UK, 2Myriad Genetic Laboratories, Salt Lake City, USA, 3University of California, San Francisco, USA, 4University of Texas Health Science Center at San Antonio, San Antonio, USA, 5Duke University Medical Center and Durham VA Medical Center, Durham, USA

High expression of prostate stem cell antigen (PSCA) is associated with Gleason score in Iranian prostate cancer patients, a tissue microarray analysis

Year:

Session type:

Jaleh Taeb1, Zahra Madjd2,5, Mojgan Asgari2,3, Maryam Abolhasani2,3, Mohammad M Farajollahi4,5
1Iran University of Medical Sciences,Dep Molecular Medicine, Tehran, Iran, 2Iran University of Medical Sciences,Oncopathology Research Centre, Tehran, Iran, 3Iran University of Medical Sciences,Hasheminejad Kidney Center, Tehran, Iran, 4Iran University of Medical Sciences,Dep of Medical Biotechnology, Tehran, Iran, 5Iran University of Medical Sciences,Cellular and Molecular Research Center, Tehran, Iran

Cancer and seeking normality: A longitudinal, qualitative study to explore how patients with advanced cancer and their carers cope and maintain psychological wellbeing

Year:

Session type:

Diane Roberts1, Gunn Grande1, Mari Lloyd-Williams2, Lynn Calman3, Lynda Appleton4, Paul Large5, Sue Kernaghan5, Catherine Walshe1
1University of Manchester, Manchester, UK, 2University of Liverpool, Liverpool, UK, 3University of Southampton, Southampton, UK, 4Clatterbridge NHS Trust, Merseyside, UK, 5Patient representative, North West, UK

Deep analysis of signalling plasticity in a breast cancer kinase network during acquisition of resistance to PI3K and mTORC1/2 inhibitors

Year:

Session type:

Edmund Wilkes1,2, Pedro Cutillas1,2
1Barts Cancer Institute, Queen Mary University of London, School of Medicine and dentistry, London, UK, 2MRC Clinical Sciences Centre, London, UK

Metastatic endometrial tumours: The experience of a single institution

Year:

Session type:

Loaie El-Helw1,2, Hanaa Elkhenini1, Mojca Persic2
1Mansoura University, Mansoura, Egypt, 2Royal Derby Hospital, Derby, UK

A systematic review of outcome measures to assess toxicity during and after radiotherapy treatment for rectal cancer

Year:

Session type:

Alexandra Gilbert1, Lucy Ziegler1, Maisie Martland1, David Sebag-Montefiore1, Susan Davidson2, Galina Velikova1
1University of Leeds, Leeds, UK, 2Christie Hospital, Manchester, UK

Prognostic factors in patients with Duke’s B colorectal cancer treated at the Edinburgh Cancer Centre

Year:

Session type:

Alan Christie1, Sally Clive1, Lesley Dawson1, Catriona McLean1, Hamish Phillips1, Ewan Brown1
1Edinburgh Cancer Centre, Edinburgh, UK

Multidisciplinary decisions for newly diagnosed breast cancer: Are we following clear guidelines?

Year:

Session type:

Loaie El-Helw1, Hanaa Elkhenini1
1Mansoura University, Mansoura, Egypt

New findings from the WCRF/AICR Continuous Update Project (CUP): Coffee, glycaemic load, body fatness, physical activity and risk of endometrial cancer

Year:

Session type:

Elisa Bandera1, Hilary Powers2, Rachel Marklew3, Martin Wiseman3, Rachel Thompson3
1Rutgers Cancers Institute of New Jersey, New Brunswick, USA, 2University of Sheffield, Sheffield, UK, 3World Cancer Research Fund International, London, UK

Chemotherapy mortality rates – Which measure to use?

Year:

Session type:

Stefan Symeonides1,2, David Cameron1,2, Larry Hayward2,1
1University of Edinburgh, Edinburgh, UK, 2NHS Lothian, Edinburgh, UK

Page 25 of 78« First...25...50...Last »